Your email has been successfully added to our mailing list.

×
0.107142857142857 0.333333333333333 0.576190476190476 0.788095238095238 0.557142857142857 0.573809523809524 0.676190476190476 0.726285714285714
Stock impact report

Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At The Market” Of...

Acorda Therapeutics, Inc (ACOR)  More Company Research Source: Business Wire
Last acorda therapeutics, inc earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF $80 million up-front payment will substantially increase cash balanceSale, restructuring and other operating expense reductions will reduce annual operating expenses by approximately $40 millionTotal 2021 non-GAAP operating expense guidance expected to be $130-$140 million1At The Market (ATM) offering allows the sale of common stock at aggregate value up to $15.25 million1Supply agreement will ensure uninterrupted supply of INBRIJA (levodopa inhalation powder) to people with Parkinson’s ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into a definitive agreement to sell its INBRIJA manufacturing operations in Chelsea, Massachusetts to Catalent for $80 million in cash. In connection with the sale, Acorda and Catalent have entered into a long-term global supply agreement under which Catalent will manufacture and package INBRIJA for Acorda, ensuring an uninterrupted drug supply for Acorda’s patients and continued adherence to [Read more]
Impact snapshot Event time: ACOR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ACOR alerts

from News Quantified
Opt-in for
ACOR alerts

from News Quantified